Polymorphism exploration of CYP2D6 by AmpliChip P450 in tamoxifen breast cancer treatment
- At: 2009 FIP Congress in Istanbul (Turkey)
- Type: Presentation
- By: EBERLE, Frederic (Roche Diagnostics, Meylan, France)
The very large majority of assays of medical biology allow to screen and diagnose diseases and to the monitor the treatments. Among them, some have the specific propriety to be so much linked to the individual patient's biology and pathophysiology (old concept of "idiosyncrasy") that they directly serve the immediate adaptation of the treatment,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.